We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+7.42%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$19.3B
AUM Growth
+$783M
Cap. Flow
-$455M
Cap. Flow %
-2.35%
Top 10 Hldgs %
20.28%
Holding
1,342
New
146
Increased
332
Reduced
638
Closed
75

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$37.2M
2
PGR icon
Progressive
PGR
+$34.8M
3
NOC icon
Northrop Grumman
NOC
+$24.6M
4
RVTY icon
Revvity
RVTY
+$24.1M
5
CARR icon
Carrier Global
CARR
+$22.5M

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Healthcare 12.4%
3 Financials 11.64%
4 Consumer Discretionary 9.19%
5 Industrials 8.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
COO icon
1051
Cooper Companies
COO
$13.7B
$279K ﹤0.01%
2,820
+4
+0.1% +$392
FNV icon
1052
Franco-Nevada
FNV
$41.4B
$278K ﹤0.01%
1,925
-185
-9% -$26.8K
JJSF icon
1053
J&J Snack Foods
JJSF
$1.46B
$276K ﹤0.01%
1,584
-143
-8% -$24.1K
PCH
1054
DELISTED
PotlatchDeltic
PCH
$275K ﹤0.01%
+5,191
New +$299K
AMX icon
1055
America Movil
AMX
$77.1B
$274K ﹤0.01%
18,306
-19,839
-52% -$295K
IART icon
1056
Integra LifeSciences
IART
$1.52B
$273K ﹤0.01%
4,015
+126
+3% +$8.91K
LOV
1057
DELISTED
Spark Networks SE American Depositary Shares
LOV
$273K ﹤0.01%
52,889
HEDJ icon
1058
WisdomTree Europe Hedged Equity Fund
HEDJ
$1.82B
$272K ﹤0.01%
7,156
BSX icon
1059
Boston Scientific
BSX
$67.6B
$270K ﹤0.01%
6,354
-366
-5% -$15.4K
QTWO icon
1060
Q2 Holdings
QTWO
$3.64B
$270K ﹤0.01%
2,639
-66
-2% -$6.61K
BXP icon
1061
Boston Properties
BXP
$11B
$267K ﹤0.01%
+2,340
New +$263K
PRN icon
1062
Invesco Dorsey Wright Industrials Momentum ETF
PRN
$427M
$267K ﹤0.01%
2,686
IEV icon
1063
iShares Europe ETF
IEV
$1.64B
$266K ﹤0.01%
5,000
BIP icon
1064
Brookfield Infrastructure Partners
BIP
$18.6B
$265K ﹤0.01%
7,179
IPAR icon
1065
Interparfums
IPAR
$3.99B
$264K ﹤0.01%
3,680
-286
-7% -$21.1K
NGG icon
1066
National Grid
NGG
$81.6B
$264K ﹤0.01%
4,688
+478
+11% +$27.2K
TCRR
1067
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$264K ﹤0.01%
16,095
-711
-4% -$14.4K
SGOL icon
1068
abrdn Physical Gold Shares ETF
SGOL
$6.97B
$259K ﹤0.01%
15,250
IQV icon
1069
IQVIA
IQV
$35.6B
$257K ﹤0.01%
+1,063
New +$245K
MDB icon
1070
MongoDB
MDB
$24.9B
$257K ﹤0.01%
713
-684
-49% -$212K
NRC icon
1071
NRC Health Common Stock
NRC
$479M
$257K ﹤0.01%
+5,612
New +$267K
DXC icon
1072
DXC Technology
DXC
$1.68B
$254K ﹤0.01%
6,536
-1,330
-17% -$47.5K
SLAMU
1073
DELISTED
Slam Corp. Unit
SLAMU
$254K ﹤0.01%
+25,512
New +$255K
BLKB icon
1074
Blackbaud
BLKB
$1.59B
$252K ﹤0.01%
3,299
-234
-7% -$16.9K
ICLN icon
1075
iShares Global Clean Energy ETF
ICLN
$2.35B
$251K ﹤0.01%
10,720
+5,520
+106% +$126K

Similar funds

Glenmede Trust's Q2 2021 Portfolio in Review

As of Q2 2021, Glenmede Trust held 1,342 positions worth $19.3B, up 4.2% from $18.6B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Glenmede Trust's Q2 2021 filing shows 146 new, 332 increased, 638 reduced and 75 closed positions. Its largest new stake was Virtu Financial: 627,026 shares worth $17.3M. The largest sale was McKesson, an estimated $82.9M.

By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.

  • Glenmede Trust's largest Q2 2021 buy was Virtu Financial: 627,026 shares worth $17.3M.
  • Glenmede Trust added most to TJX Companies in Q2 2021, an estimated $37.2M increase.
  • Glenmede Trust's biggest Q2 2021 reduction was McKesson, cutting an estimated $82.9M.
  • Glenmede Trust fully exited Western Alliance Bancorporation in Q2 2021, selling an estimated $19.5M.
  • Glenmede Trust's ten largest holdings make up 20% of its $19.3B portfolio in Q2 2021.
  • Glenmede Trust opened 146 new positions and closed 75 in Q2 2021.
  • Glenmede Trust's portfolio value rose 4.2% quarter-over-quarter to $19.3B.

Based on Glenmede Trust's 13F filing for Q2 2021, filed 16 Aug 2021.